Evaluation of liver biopsies in hepatitis C is aimed at confirming the
clinical and serologic diagnosis, grading of necroinflammatory activi
ty, staging of consecutive fibrosis, ruling out or confirming liver di
seases of different etiology, and assessment of therapeutic effects. U
sually, the course of chronic hepatitis C virus (HCV) infection is slo
w with mild inflammatory changes. Nevertheless, even in mild asymptoma
tic chronic hepatitis C episodes of higher inflammatory activity assoc
iated with extensive piecemeal necrosis and porto-central bridging, ne
crosis can accelerate the course of the disease. For this reason, the
traditional, morphologically based classification of chronic hepatitis
and the term ''chronic persistent hepatitis'' have lost their predict
ive usefulness, especially in hepatitis C. Chronic hepatitis should be
characterized by etiologic designation as well as grade and stage of
the disease. Portal lymphoid aggregates, some inflammatory bile duct d
amage and mild steatosis are the most characteristic features by which
hepatitis C can be differentiated from other progressive inflammatory
liver diseases. Antibodies directed against HCV antigens allow identi
fication of viral proteins by immunohistochemistry. Immunostaining for
hepatitis B antigens, for alpha-l-antitrypsin and copper staining are
helpful in detecting hepatitis B and congenital liver diseases (Wilso
n's disease, alpha-l-antitrypsin deficiency) as possible causes of chr
onic progressive inflammatory liver disease. Centrilobular Mallory's h
yalin, identified by immunostaining for ubiquitin in combination with
perivenular fibrosis, is helpful in diagnosing concomitant alcoholic l
iver disease. In our own biopsy material (n = 100) and autopsy materia
l (n = 58), HIV/HCV-coinfected patients have a significantly higher ra
te of fibrosis and cirrhosis than HIV patients without HCV infection.
Hepatitis C can apparently aggravate the course of HIV infection. Our
morphologic findings support the clinical observation that chronic HCV
infection seems to be the main cause of liver failure, especially in
the risk group of HCV/HIV-coinfected hemophiliacs. (C) European Associ
ation for the Study of the Liver.